Drug factory · FDA FEI 3002806556

Boehringer Ingelheim Pharma GmbH and Co. KG

Binger Strasse 173, Ingelheim am Rhein, Germany

Germany: 1

Problems found, fixed voluntarily at FDA's last inspection, May 15, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

8 drug inspections on record since 2009: 2 with no problems, 5 with problems fixed voluntarily, 1 with FDA action.

What it does, for whom

DrugRoleForNDC
AtropineMakes the active ingredient and tests it Alcon Laboratories, Inc. 0065-0303, 0065-0817
DabigatranMakes it, makes the active ingredient, tests it, packages it and labels it Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0108, 0597-0355, 0597-0360 +6
Empagliflozin and LinagliptinMakes it, makes the active ingredient, packages it and labels it Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0164, 0597-0182
EpinephrineMakes the active ingredient Amneal Pharmaceuticals 0115-1694, 0115-1695
Hydrochlorothiazide and TelmisartanMakes it, packages it and labels it Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0042, 0597-0043, 0597-0044
LinagliptinMakes the active ingredient Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0140
Linagliptin and MetforminMakes it, makes the active ingredient, packages it and labels it Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0146, 0597-0147, 0597-0148
OlodaterolMakes it, makes the active ingredient, packages it and labels it Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0192
Olodaterol and TiotropiumMakes it, makes the active ingredient, packages it and labels it Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0155
TipranavirMakes the active ingredient Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0003

FDA inspection history

EndedResultProgramProblems noted
May 15, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 7, 2021Problems found, fixed voluntarilyDrug Quality Assurance—
May 4, 2018Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 8, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 7, 2014Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 12, 2012Serious problems, FDA actionDrug Quality Assurance—
Feb 5, 2010No problems foundDrug Quality Assurance—
Jun 5, 2009No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture; label; manufacture; pack.